A detailed history of Game Plan Financial Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Game Plan Financial Advisors, LLC holds 1,998 shares of ABBV stock, worth $361,917. This represents 0.22% of its overall portfolio holdings.

Number of Shares
1,998
Previous 2,091 4.45%
Holding current value
$361,917
Previous $358,000 10.06%
% of portfolio
0.22%
Previous 0.21%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $15,237 - $18,537
-93 Reduced 4.45%
1,998 $394,000
Q2 2024

Aug 01, 2024

BUY
$154.79 - $180.76 $15,943 - $18,618
103 Added 5.18%
2,091 $358,000
Q4 2023

Apr 12, 2024

SELL
$137.6 - $154.97 $920,681 - $1.04 Million
-6,691 Reduced 77.09%
1,988 $308,000
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $890,854 - $1.07 Million
6,441 Added 287.8%
8,679 $1.4 Million
Q3 2022

Nov 02, 2022

BUY
$134.21 - $153.93 $2,013 - $2,308
15 Added 0.67%
2,238 $300,000
Q1 2022

Apr 22, 2022

SELL
$131.98 - $163.75 $46,193 - $57,312
-350 Reduced 13.6%
2,223 $360,000
Q3 2021

Oct 26, 2021

SELL
$106.4 - $120.78 $1,276 - $1,449
-12 Reduced 0.46%
2,573 $278,000
Q1 2021

Apr 28, 2021

SELL
$102.3 - $112.62 $9,002 - $9,910
-88 Reduced 3.29%
2,585 $281,000
Q4 2020

Jan 19, 2021

BUY
$80.49 - $108.67 $215,149 - $290,474
2,673 New
2,673 $286,000
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $246,991 - $289,886
-2,875 Closed
0 $0
Q2 2020

Aug 03, 2020

BUY
$73.37 - $98.18 $6,750 - $9,032
92 Added 3.31%
2,875 $282,000
Q1 2020

May 07, 2020

BUY
$64.5 - $97.79 $5,805 - $8,801
90 Added 3.34%
2,783 $211,000
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $194,246 - $243,043
2,693 New
2,693 $238,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Game Plan Financial Advisors, LLC Portfolio

Follow Game Plan Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Game Plan Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Game Plan Financial Advisors, LLC with notifications on news.